LINCOLN, Neb--(BUSINESS WIRE)--Celerion, a leading clinical research organization, proudly announces its recent achievement of obtaining the Clinical Laboratory Improvement Amendments (CLIA) ...

Wholly-owned laboratory has received CLIA certification from Massachusetts with full license to conduct patient testing and develop companion ...

Strategic partnership delivers scalable, CLIA-certified capillary blood testing to support rural Medicaid programs and ...

SAN DIEGO, January 20, 2026--(BUSINESS WIRE)--Crown Bioscience, a global contract research organization (CRO) and a JSR Life Sciences company, today announced that its San Diego laboratory has ...

WEST LAFAYETTE, Ind. — Amplified Sciences, a clinical-stage life sciences diagnostic company that develops tests for early, more accurate detection of challenging diseases, starting with pancreatic ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Cellworks Group, Inc., a leader in Personalized Therapy Decision Support and Precision Drug Development, today announced that its computational laboratory ...

Marlborough, Mass.-based Akoya Biosciences was awarded CLIA certification for its Advanced Biopharma Solutions lab, the company said in a Nov. 30 news release. The lab specializes in spatial biology, ...

Demand for COVID-19 tests, including over-the-counter at-home tests, has soared with the surge of the Omicron variant of the COVID-19 virus. However, health care providers, employers, and individuals ...

WATERTOWN, Mass., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Acrivon Therapeutics, Inc. (“Acrivon” or “Acrivon Therapeutics”) (Nasdaq: ACRV), a clinical stage biotechnology company discovering and developing ...

Amplified Sciences — led by CEO Diana Caldwell (right) and Chief Scientific Officer V. Jo Davisson — has received regulatory clearance under the federal Clinical Laboratory Improvement Amendments ...

Wholly-owned laboratory has received CLIA certification from Massachusetts with full license to conduct patient testing and develop companion diagnostics WATERTOWN, Mass., Feb. 18, 2026 (GLOBE ...